Mar 02 2015 Cordis is a global company with a growing portfolio of products and talented people serving healthcare systems throughout the world. While the U.S. is the largest single market 70 percent of total sales come from outside the U.S. Cordis international presence includes operations in more than 50 countries including China Japan Germany
Cordis CareersHome. Experience a career. on the cutting edge. For more than 60 years we have been building interventional vascular technology that offers higher quality and less invasive experiences for people around the world. With a global reach and vast network of resources we empower you to do your best work and unleash your full
Dec 03 2021 h2020 orienting ce nmbp 42 2020 lavola 1981 sau es ecoinnovazione srl it eifer europaisches institut fur energieforschung edf kit ewiv de universiteit gent be teknologian tutkimuskeskus vtt oy fi fraunhofer gesellschaft zur foerderung der angewandten forschung e.v. de fundacion tecnalia research innovation es solana societa agricola
Cordis Auckland by Langham Hospitality Group puts every modern amenity at your fingertips with 640 contemporary rooms and suites. From our restful Dream Beds and stylish interiors to the latest high tech connectivity we have everything you need. Learn more. Stimulating Flavours.
Model # OEM Product Name Size Price Qty PG3970BPS Cordis Palmaz Genesis Transhepatic Biliary Stent 6Fr7mm x 39mm x 80cm 7mm x 39mm x 80cm
Cordis established a legacy of high quality and minimally invasive cardiovascular products and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2 2021 Cordis is a standalone company and is committed to investing 300 million to accelerate innovation in its broad product portfolio.
Endovascular. Cordis’ products and solutions for the endovascular suite aim to reduce the cost and complexity of endovascular healthcare without compromising clinical outcomes. Our endovascular portfolio is comprised of Sheaths Access Accessories Diagnostic Guidewires Crossing Devices Diagnostic Catheters Steerable Guidewires Guiding
Aug 02 2021 Cordis CEO Shar Matin said We believe that an independent Cordis company combined with an innovative approach to bring differentiated products to market will allow us to create incremental
Mar 12 2021 Dive Brief Medical supplies and drugs distributor Cardinal Health on Friday announced it h as signed a definitive agreement to sell its Cordis business to private equity firm Hellman Friedman for approximately 1 billion. Cardinal in 2015 bought the cardiovascular device manufacturer from Johnson Johnson for 1.9 billion but was dogged in subsequent
Oct 25 2015 Cordis was taken over in 1996 by Johnson Johnson and in early October of this year Cardinal Health Inc. a giant Ohio based supplier of pharmaceutical medical and surgical products acquired
Founded 1959. Type Subsidiary or Business Segment. Industry Health Care Products Manufacturing. Revenue 25 to 50 million USD Cordis offers a full suite of interventional cardiology and endovascular devices that cover the breadth of a procedure from access to closure. We have a global commercial footprint and state of the art
Cordis is a global leader in delivering innovative differentiated cardiovascular and endovascular devices. For over 60 years we’ve pioneered products.
Nov 02 2021 With a reputation for clinical acumen training and services Cordis established a legacy of innovation in high quality and less invasive cardiovascular products and built a
Oct 04 2015 Cordis had annual sales in calendar year 2014 of approximately 780 million split almost evenly between cardiology and endovascular products. Cordis is a global company with a growing portfolio of products and talented people serving health care systems throughout the
Aug 27 2018 cordis is the preferred central line in trauma. unstable GI bleeds ruptured AAAs or any other situation in which the necessity for rapid transfusion of blood products is anticipated. It is a short wide single lumen central venous catheter that is perfect for rapid large volume infusions. The kit looks like this.
The Cordis SUPERTORQUE and SUPERTORQUE Plus line of diagnostic catheters are used in coronary angiography. ANGIOGUARD RX Guidewire System The Cordis ANGIOGUARD RX Guidewire System is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70 during carotid stenting procedures .
Demonstrates knowledge of Cordis products and clinical applications of such products Responsible for designing and implementing an overall risk management process for medical devices sold by Cordis.
ProductsCordis As of October 2015 Cordis is a part of Cardinal Health bringing together two important players in the healthcare industry and creating an unmatched combined offering in the cardiovascular space that will ensure greater access to quality products and services worldwide.
CORDIS is the primary source of results from EU funded projects since 1990. List projects by framework programme. See all H2020 projects See all FP7 projects. See latest results. See latest Results in Brief See latest Report Summaries See latest Project Deliverables
Please note that information contained in this website is not intended or recommended as a substitute for professional medical advice or for diagnosis purposes. Please also contact your Cordis representative for availability or the products and registration status.
Mar 15 2021 Cardinal Health and H F share the same passion of providing excellent quality medical products to customers and the former is optimistic about the future of Cordis business under the able
Company Description Cordis de México S.A. de C.V. is located in Ciudad Juárez CHIHUAHUA Mexico and is part of the Medical Equipment and Supplies Manufacturing Industry. Cordis de México S.A. de C.V. has 5 000 total employees across all of its locations and generates 183.16 million in sales USD .
Cordis is devoted to our environment and the community around us. Our hotels use many locally sourced renewable materials. Our uniforms are made from earth friendly materials. Our comfortable cars are hybrids. Our stores sell ethical and locally produced items including natural products from our spa.
Bridgewater NJ March 12 2013 Cordis Corporation a worldwide leader in the development of interventional vascular technology today announced it has completed the acquisition of Flexible Stenting Solutions Inc. a leading developer of innovative flexible peripheral arterial venous and biliary stents. Currently Cordis markets the S.M.A.R.T. Vascular Stent worldwide.
Cordis is a global leader in delivering innovative differentiated cardiovascular and endovascular devices. For over 60 years we’ve pioneered products.